Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,959 | 202 | 99.5% |
| Education | $15.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $640.84 | 56 | $0 (2023) |
| Janssen Biotech, Inc. | $602.32 | 41 | $0 (2024) |
| Amgen Inc. | $276.24 | 18 | $0 (2023) |
| Genentech USA, Inc. | $199.14 | 12 | $0 (2019) |
| UCB, Inc. | $188.40 | 9 | $0 (2019) |
| Celgene Corporation | $177.30 | 16 | $0 (2019) |
| Horizon Pharma plc | $171.49 | 9 | $0 (2018) |
| Lilly USA, LLC | $137.50 | 9 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $104.95 | 7 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $70.24 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.88 | 1 | Janssen Biotech, Inc. ($17.88) |
| 2023 | $75.17 | 4 | AbbVie Inc. ($53.67) |
| 2022 | $339.67 | 27 | ABBVIE INC. ($241.03) |
| 2021 | $528.34 | 43 | AbbVie Inc. ($208.24) |
| 2020 | $277.35 | 18 | Janssen Biotech, Inc. ($191.00) |
| 2019 | $135.58 | 7 | PFIZER INC. ($26.42) |
| 2018 | $752.63 | 46 | Amgen Inc. ($171.24) |
| 2017 | $847.12 | 57 | Celgene Corporation ($136.37) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 9 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/20/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $23.23 | General |
| 01/11/2017 | Takeda Pharmaceuticals America, Inc. | — | Food and Beverage | In-kind items and services | $10.89 | General |
| 01/05/2017 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 1,795 | 48,185 | $1.2M | $358,217 |
| 2022 | 41 | 1,976 | 37,538 | $942,791 | $302,595 |
| 2021 | 31 | 1,827 | 8,094 | $453,840 | $193,445 |
| 2020 | 34 | 1,728 | 16,052 | $1.1M | $537,145 |
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 2 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $704.00 | $494.56 | 70.3% |
| 83735 | Magnesium level | Office | 2023 | 58 | 67 | $2,010 | $440.19 | 21.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 25 | 25 | $1,875 | $411.50 | 21.9% |
| 84550 | Uric acid level, blood | Office | 2023 | 22 | 58 | $1,218 | $256.94 | 21.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 12 | 13 | $780.00 | $170.56 | 21.9% |
| 86200 | Measurement of antibody for rheumatoid arthritis assessment | Office | 2023 | 13 | 13 | $481.00 | $164.97 | 34.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 32 | 53 | $795.00 | $164.83 | 20.7% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 18 | 20 | $600.00 | $127.60 | 21.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 35 | 51 | $765.00 | $112.20 | 14.7% |
| 86431 | Rheumatoid factor level | Office | 2023 | 15 | 15 | $255.00 | $83.40 | 32.7% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 12 | 29,400 | $459,200 | $108,907 | 23.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 47 | 4,680 | $154,440 | $78,974 | 51.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 268 | 519 | $123,522 | $46,428 | 37.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 21 | 138 | $42,780 | $15,539 | 36.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 56 | 179 | $29,535 | $11,186 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $17,995 | $7,202 | 40.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 206 | 390 | $18,330 | $4,062 | 22.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 173 | 367 | $12,845 | $2,813 | 21.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 34 | 34 | $2,584 | $2,330 | 90.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 38 | 44 | $6,248 | $2,275 | 36.4% |
| 86480 | Tuberculosis test, gamma interferon | Office | 2022 | 37 | 37 | $6,438 | $2,264 | 35.2% |
| 82306 | Vitamin d-3 level | Office | 2022 | 67 | 72 | $5,472 | $2,101 | 38.4% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 40 | 42 | $3,360 | $1,706 | 50.8% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2022 | 31 | 56 | $4,125 | $1,559 | 37.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 44 | $1,716 | $1,334 | 77.7% |
About Dr. Sonia Yousuf, MD
Dr. Sonia Yousuf, MD is a Rheumatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1194851394.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sonia Yousuf, MD has received a total of $2,974 in payments from pharmaceutical and medical device companies, with $17.88 received in 2024. These payments were reported across 203 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,959).
As a Medicare-enrolled provider, Yousuf has provided services to 7,326 Medicare beneficiaries, totaling 109,869 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Austin, TX
- Active Since 02/24/2007
- Last Updated 01/27/2016
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1194851394
Products in Payments
- RINVOQ (Biological) $312.38
- TREMFYA (Drug) $301.61
- Enbrel (Biological) $261.24
- Cimzia (Drug) $188.40
- REMICADE (Biological) $139.21
- Humira (Biological) $137.90
- SKYRIZI (Biological) $127.07
- RAYOS (Drug) $115.54
- Actemra (Biological) $112.01
- ORENCIA (Biological) $104.95
- Rituxan (Biological) $87.13
- STELARA (Biological) $81.91
- SIMPONI ARIA (Biological) $79.59
- FORTEO (Drug) $70.81
- COSENTYX (Biological) $70.24
- TALTZ (Drug) $66.69
- HUMIRA (Biological) $63.49
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $62.12
- KRYSTEXXA (Drug) $55.95
- KRYSTEXXA (Biological) $53.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Austin
Dr. Robert Koval, Md, MD
Rheumatology — Payments: $67,062
Paul Pickrell, Md, MD
Rheumatology — Payments: $29,321
Joseph Martinez, Md, MD
Rheumatology — Payments: $21,904
Dr. Louis Robinett, M.d, M.D
Rheumatology — Payments: $6,520
Marco Lopez Velazquez, M.d, M.D
Rheumatology — Payments: $3,941
Dr. Samir Patel, M.d, M.D
Rheumatology — Payments: $1,565